This paper is in the following e-collection/theme issue:

Public Health Policy (98) Vaccination and Immunization in the Digital Age (442) HIV/AIDS/STI Prevention and Care (1043) Prevention and Health Promotion (1362)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43893, first published .
Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis

Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis

Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis

Authors of this article:

Qiang Wang1, 2 Author Orcid Image ;   Liuqing Yang1 Author Orcid Image ;   Lan Li3 Author Orcid Image ;   Chang Liu1 Author Orcid Image ;   Hui Jin1, 4 Author Orcid Image ;   Leesa Lin2, 5, 6 Author Orcid Image
Article Authors Cited by (50) Tweetations (3) Metrics

Journals

  1. AlMuammar S, Albogmi A, Alzahrani M, Alsharef F, Aljohani R, Aljilani T. Herpes zoster vaccine awareness and acceptance among adults in Saudi Arabia: a survey-based cross-sectional study. Tropical Diseases, Travel Medicine and Vaccines 2023;9(1) View
  2. Gu W, Liu Y, Chen Q, Wang J, Che X, Du J, Zhang X, Xu Y, Zhang X, Jiang W, Wang J, Xie Q, Lu Z, Yang Y, Gu L, Chen J. Acceptance of influenza vaccination and associated factors among teachers in China: A cross-sectional study based on health belief model. Human Vaccines & Immunotherapeutics 2023;19(3) View
  3. Alleft L, Alhosaini L, Almutlaq H, Alshayea Y, Alshammari​​ S, Aldosari M, Alateeq F. Public Knowledge, Attitude, and Practice Toward Herpes Zoster Vaccination in Saudi Arabia. Cureus 2023 View
  4. Roberts E. Highlights From the European Respiratory Society Congress 2023: Chronic Obstructive Pulmonary Disease and Severe Asthma. EMJ Respiratory 2023:2 View
  5. Ponticelli D, Antonazzo I, Losa L, Zampella A, Di Marino F, Mottola G, Fede M, Gallucci F, Magliuolo R, Rainone A, Del Giudice C, Arcari A, Ferrara P. Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy. Medicina 2024;60(1):93 View
  6. Ponticelli D, Losa L, Antonazzo I, Zampella A, Di Marino F, Mottola G, Fede M, Gallucci F, Magliuolo R, Rainone A, Arcari A, Del Giudice C, Ferrara P. Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy. Infectious Disease Reports 2024;16(1):128 View
  7. George S, Regan J, Awan A, O’Connor M, Foster A, Raymond K, Gorfinkel I, McNeil S. Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients. Human Vaccines & Immunotherapeutics 2024;20(1) View
  8. Sansone V, Miraglia del Giudice G, Della Polla G, Angelillo I. Knowledge, Attitudes, and Coverage of Recommended Vaccinations in Individuals with Chronic Medical Conditions: A Cross-Sectional Telephone Survey in Italy. Vaccines 2024;12(3):336 View
  9. De Caro F, Malatesta F, Pecoraro N, Capunzo M, Carpinelli L, Caruccio S, Cersosimo G, Costantino M, Giordano C, Longanella W, Patella V, Saggese Tozzi A, Savarese G, Sinopoli P, Vozzella E, Moccia G. Anti-Herpes Zoster Vaccination of Fragile Patients in Hospital Setting: A Nudge Intervention in Italy. Vaccines 2024;12(4):442 View
  10. AlKhowailed M, Alotaibi H, Aljurays A, Mohammad R, Alqahtani G, Al Abdulmonem W, Alhumidi A, Alhomaidan H, Alqossayir F. Public Perception in Saudi Arabia Toward Herpes Zoster and Its Vaccination: A Cross-Sectional Study. Cureus 2024 View
  11. Xia Y, Wang M, Hu M, Wang Y, Yuan B, Zhu D, He P. Preferences and Willingness to Pay for Herpes Zoster Vaccination Among Chinese Adults: Discrete Choice Experiment. JMIR Public Health and Surveillance 2024;10:e51242 View
  12. Nikkels A, Schoevaerdts D, Kauffmann F, Strubbe F, Bensemmane S. Herpes zoster in Belgium: a new solution to an old problem. Acta Clinica Belgica 2024;79(3):205 View
  13. Yang M, Yang Y, Li S. Understanding invisible pain in the older adult: a content analysis of social media’s representation of herpes zoster vaccine. Frontiers in Public Health 2024;12 View
  14. D’Addio F, Lazzaroni E, Lunati M, Preziosi G, Ercolanoni M, Turola G, Marrocu C, Cicconi G, Sharma S, Scarioni S, Montefusco L, Pastore I, Morpurgo P, Rossi A, Gandolfi A, Tinari C, Rossi G, Ben Nasr M, Loretelli C, Fiorina R, Grassa B, Terranova R, Bucciarelli L, Berra C, Cereda D, Zuccotti G, Borriello C, Fiorina P. Vaccinome Landscape in Nearly 620 000 Patients With Diabetes. The Journal of Clinical Endocrinology & Metabolism 2025;110(5):e1590 View
  15. Wang J, Jin P, Jin H, Wang Q, Zhu F, Li J. Cost-Effectiveness Analysis of Herpes Zoster Vaccination in a Chinese Population: Recombinant Subunit Vaccine versus Live Attenuated Vaccine. Vaccines 2024;12(8):872 View
  16. Roesner L, Gupta M, Kopfnagel V, van Unen N, Kemmling Y, Heise J, Castell S, Jiang X, Riemann L, Traidl S, Lange B, Sühs K, Illig T, Strowig T, Li Y, Förster R, Huehn J, Schulz T, Werfel T, Bošnjak B, Gutierrez Jauregui R, Jenniches F, Klopp N, Lesker T, Stangel M. The RESIST Senior Individuals Cohort: Design, participant characteristics and aims. GeroScience 2024;47(3):3299 View
  17. Zhang X, Liu Z, Liu G, Wei Z, Qin Z, Li R, Liu Y, Jiang Z, Min Y, Peng X. Causal effect of gut microbiota on occurrence of herpes zoster and postherpetic neuralgia, and role of Tyzzerella 3. European Journal of Medical Research 2024;29(1) View
  18. Ahmed S, Lauran M, Ugwoke A, Walton T, Holroyd C, Galloway J. The relationship between Zoster serology, vaccination uptake and infection rates: a single-centre cross-sectional study. Rheumatology Advances in Practice 2024;8(4) View
  19. Tsai Y, Leung J, Anderson T, Zhou F, Singleton J. Herpes zoster vaccination among Medicare beneficiaries with and without prescription drug coverage. Vaccine 2025;43:126537 View
  20. Dyda A, Lawford H, Lau C, Sampson K. Investigating behaviours and attitudes regarding recommended vaccination in adults 50 years and above in Australia. Australian Journal of Primary Health 2024;30(6) View
  21. Grudziąż-Sękowska J, Sękowski K, Grześczyk-Nojszewska Z, Kamińska A, Sierpiński R, Ostrowski J, Pinkas J, Jankowski M. Public Awareness and Willingness to Vaccinate Against Herpes Zoster: A Nationwide Cross-Sectional Study in Poland. Vaccines 2024;12(12):1393 View
  22. Liu Y, Cao Y, Li Y, Liu S, Xu Y, Yang W, Feng L. Preferences for and drivers of adult vaccination clinic site selection: A cross-sectional study in 30 provinces in China. Human Vaccines & Immunotherapeutics 2025;21(1) View
  23. Sun X, Zhang L, Zhang T, Sun J, Xu Y, Liu L, Liu Y, Hu R, Fu Y, Wang Z, Sun H. Surveillance on the coverage of herpes zoster vaccine and post-marketing adverse events in Jiangsu province, China. Human Vaccines & Immunotherapeutics 2025;21(1) View
  24. Zhang J, Zhang S, Jia B, Bai Y, Li Z, Liu F, Hu Y, Guo X, Ma J, Li S, Shi Q. A cross-sectional study exploring the predictors of herpes zoster vaccination for people aged over 50 years old in Chaoyang district, Beijing. Frontiers in Public Health 2025;12 View
  25. Volobuieva O. Cytokine Profile in Patients with Herpes Zoster. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine" 2024;(51):534 View
  26. De Caro F, Pecoraro N, Capunzo M, Caruccio S, Caggiano F, Cersosimo G, Costantino M, Longanella W, Malatesta F, Tomeo M, Savarese G, Sinopoli P, Vozzella E, Moccia G. An Exploratory Investigation of Representations of Herpes Zoster and Adjuvanted Recombinant Herpes Zoster Vaccination in a Sample of Fragile Adults in Italy. Pathogens 2025;14(2):145 View
  27. Zhang X, Zhao T, Cai X, Zhang W, Huang N, Du J, Zeng J, Lu Q, Zhang Y, Cui F. Are health education effective to improve herpes zoster vaccine willingness in vulnerable elderly. Vaccine 2025;54:126975 View
  28. Shantakumar S, Choo E, Parikh R, Kwon T, Kim H, Vandervoort L, Grillo V, Lee J. Patient preferences toward herpes zoster vaccination among individuals aged 50 years or older in South Korea: Findings from a discrete choice experiment. Human Vaccines & Immunotherapeutics 2025;21(1) View
  29. Xia Y, Zhu W, Shi Z, Shen Y, Cui C, Ai J, Yuan Y, Ye X, Zhu D, He P. Herpes zoster vaccination coverage and factors associated among adults aged 40 and older in China: A population-based survey. Vaccine 2025;56:127122 View
  30. Yuan B, Long C, Wang M, Maitland E, Nicholas S, Qin X, Zhao W, Zhu D, He P. The barriers and facilitators of herpes zoster vaccination intentions of urban residents in China: a qualitative study. Global Health Research and Policy 2025;10(1) View
  31. Oleszko M, Zapolnik P, Czajka H. Herpes Zoster Vaccination: Insights into Efficacy, Safety, and Guidelines. Vaccines 2025;13(5):477 View
  32. Lee S, Lee K, Oh J, Kim H, Son Y, Kim S, Park J, Kang J, Pizzol D, Lee J, Woo H, Lee H, Yon D. Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study. European Heart Journal 2025;46(30):2991 View
  33. Maltezou H, Cassimos D, Sipsas N, Medic S. Adult Vaccinations Today—Innovations and Challenges for the Coming Years. Vaccines 2025;13(6):583 View
  34. Chen Y, Li R, Liu Y, Guo R, He M, Li W, Gao X, Zhang W, Wei Y, Chen Z, Liu H, Zhang X. Family health and willingness to Receive Self-paid vaccines: the role of Self-efficacy and health literacy. Psychology, Health & Medicine 2025:1 View
  35. Gao Y, Wei T, Gong R, Cai L, Sheng Y, Shang M, Ni Y. Development of a herpes zoster vaccination intention scale and identification of factors associated with vaccine hesitancy among middle-aged and older attendees in community health centers: A Protection Motivation Theory based study. Human Vaccines & Immunotherapeutics 2025;21(1) View
  36. Geng Y, Lu B, Xie W, Wang Y, Deng X, Zhao J, Li G, Zhang X, Song Z, Zhang Z. From Awareness to Action: Addressing Knowledge Barriers and Promoting Herpes Zoster Vaccination in Chinese Rheumatic Disease Patients. Vaccines 2025;13(7):674 View
  37. Lin J, Dai Z, Li C, He W. Change in herpes zoster vaccination uptake before and during the COVID-19 pandemic in the United States older adults. Vaccine 2025;62:127503 View
  38. Kousoulas K, Dutta O, Mohan H, Santana A. A Tiered Vaccine Framework: Prioritizing Tier 1 Vaccines to Restore Public Confidence. Hygiene 2025;5(3):33 View
  39. Dosh H, Almaghrabi M, Al Qurashi J. Herpes Zoster Vaccine Uptake in Saudi Arabia: Factors Influencing Adults’ Willingness to Receive the Vaccine. Cureus 2025 View
  40. Shantakumar S, Litt J, Booy R, Vandervoort L, Grillo V, Bandy E, Parikh R. Herpes zoster vaccination and vaccine preferences among persons aged 50–64 years in Australia: Findings from a discrete choice experiment. Human Vaccines & Immunotherapeutics 2025;21(1) View
  41. Liu L, Zhang Q, Shu Y, Wang L, Shuai Z, Chu M, Zhang Z, Zhang R. Cost Effectiveness of Recombinant Zoster Vaccine and Live-Attenuated Vaccine Against Herpes Zoster for Adults Aged 50 and Over in China. PharmacoEconomics - Open 2025;9(6):887 View
  42. Alamri A, Althaqafi A, Salawati R, Asiri R, Aldugman M, Al Saleh M, AlAsmari B, AlBraik M, Ghazy R. Awareness and uptake of herpes zoster vaccine among patients with diabetes mellitus in the Aseer Region, Saudi Arabia: A cross-sectional study. Medicine 2025;104(36):e44356 View
  43. Lin Z, Wang H, Ma C, Ju R, Cao Y, Lin P. Evaluating the efficacy of machine learning in predicting postherpetic neuralgia: a systematic review and meta-analysis. Frontiers in Neurology 2025;16 View
  44. Wang Y, Wang M, Xia Y, Zhu D, Shi Z, He P. Willingness to pay for herpes zoster vaccination in urban China. Human Vaccines & Immunotherapeutics 2025;21(1) View
  45. Deng Y, Wang T, Yu L, Fu X, Luo Y, Chen F. Relationship among service accessibility, social norms, herpes zoster vaccination intention of middle-aged and older adults in Chongqing: mediating role of perceived usefulness. Frontiers in Public Health 2025;13 View
  46. AlSaif H, AlMuaawi L, Alsenani S, Aldalaqan N, Mulia Y, Alqazlan F, Alsheikh S, Alsaidan M, Alshehri N, Alrasheed A. Uptake, Willingness, and Determinants of Herpes Zoster Vaccination in Adults with Chronic Diseases in Riyadh, Saudi Arabia. Healthcare 2025;13(19):2495 View
  47. Cevasco K, Alghamdi A, Vadakkepatt G, Zaidi J, Roess A. Vaccination risk perception attitude framework market segmentation with psychographic factors. Journal of Social Marketing 2025;15(4):495 View
  48. Wang X, Shang S, Zou T, Hu Y, Zhang E, Li Y, Zhou J, Fang Q. Drivers of herpes zoster vaccine hesitancy in adults aged 50 and above: A machine learning approach. Vaccine 2025;66:127838 View
  49. 郑 嘉. Herpes Zoster Vaccination and Influencing Factors of Vaccination Willingness among Older Adults in Chongqing. Statistics and Application 2025;14(10):163 View
  50. Huang Z, Li Q, Tang Z, Liu S, Zhong D, Sun Q, Wang J, Huang X, Qiu Y, Zhu J, Zhu X, Wang R, He W, Zhao R, Zhang M, Luo H, Luo C, Xu D. Effectiveness of rapid verbal persuasion in promoting herpes zoster vaccination among older adults in China: study protocol of a two-arm randomised controlled trial. BMJ Open 2025;15(11):e108051 View